Investment Q&A

Q: I know you are not a fan of covered call ETF's and I know why. I have used some of these short term for yield when I feel the underlying securities are fully valued and I am just looking for yield. My question is on a yield of say 8% where the underlying dividend is say 4% and the premium is 4% who keeps giving up this premium? There is a lot of money in these covered call ETF's now and I don't know who can keep losing money on covered calls to provide this income premium.

Q: Did you learned anything new at the conference call? Still skeptical about their forecasts?

Thanks

Q: On March 4 you wrote, "We do like the outlook for REITs and think that as rates stabilize and even decline, the sector should benefit. Out of the two REITs mentioned we like XRE better due to the bigger size and slightly lower expense ratio."

On January 12 you wrote, "HCRE is an equal-weight REIT ETF, which has a small AUM of $48.3M, a relatively low MER of 0.33%, and a yield of 5.9%.

ZRE is also an equal-weight REIT ETF, but has a much larger AUM of $583.7M, an MER of 0.61%, and a yield of 5.1%. XRE is not equal-weight, has a large AUM of $1.0B, a yield of 5.4%, and an MER of 0.61%.

ZRE has outperformed XRE over a long period of time, and thus we like the equal-weight approach."

Can you please clarify your preference for either XRE or ZRE and the main reason for that preference? I gather your preference is for ZRE given it is part of one of your portfolios. It is just that your March 4 response has led me to wonder.

Thanks as always for your expertise.

Q: I held equal positions in Crwd Ftnt and Panw. Last week I trimmed 1/3 of my Crwd at 363 when it bounced up for a large gain. Crwd has dropped back a bit to the 320s. I am thinking of selling my Panw at a small gain and buying back my Crwd and adding to Ftnt.
What do you think of this plan? I appreciate all your good advice.
Thanks Peter

Q: Your thoughts on the high payout ratio for Bce??
Thx

Q: I understand they report Tuesday and I see a short position of approx 20%. As a stock holder I know it can be volatile. Do you have a read on expectations for the quarter?
Thank you.
David

Q: What are the key attributes of CLBT, that make it a top US non-tech small cap pick for 5i? Would you see CLBT as a takeover candidate, by someone like AXON? Would you buy CLBT now for a long term investment?

Q: Do you have a target price for WSP? What %
Would you let it have ??
Thx

Q: Lion Electric LEV) share price is down considerably (almost order of magnitude lower) over the past few years. I thought Amazon was a private investor in LEV (please confirm) LEV has production. Is this a good time to buy LEV for the eventual uptake of EV sales....at least in the commercial vehicle space? Your thoughts and comments greatly appreciated.

Q: Hi,

Down over 50% on NVEI since my purchases back in 2021 and mid 2023. Is it time to throw this weed into the trash? Holding between my TFSA and margin accounts and its less than 1% of my holdings now. This is one of the larger losers in my portfolio and I would likely roll it into one of LMN, CSU, TOI, TVK, or HPS.A. Thoughts on the recovery potential or is just better to proceed and dump this one?

Thanks!

Q: My healthcare sector is very low. I will buying for within my TFSA account and wonder if the ETF XHC would be good ? I can also buy 3 US healthcare companies as I would have enough funds to do so. What would be the best 3 US healthcare companies you would buy if this is preferred over the EFT?

Thanks

Q: BBU owns(last reported 28%) of Bre.Complete silence on Bre even though belongs to the famous BN group. and paying a great dividend,currently 9.45% for an extended period of time.Why?Please short comment on last Q results .When is the next report and estimated Rev.& Eps.Please comment on co.I have held it for a few years and at a current loss of of 14.7% Add,Hold or Sell. Txs for U usual great services & views

Q: if chrd purchase of erf is completed, do you think chrd would list on the tsx. If not would they possibly sell -off some canadian assets.

Q: I have been having a hard time pulling the trigger on Eli Lilly.

It has doubled in the last year.

I know that it is recommended, but it looks potentially overvalued.

Does there long term financials justify the current price?

Should I continue to wait for a pullback, that may never come;)

Q: Please rate each one for growth potential (1=poor, 10=good) over the next year and why for each

Q: Good morning,

Have you done any work on what asset classes or equity sectors significantly outperformed/underperformed while Trump was President from 2016-2020. I recall that that the USD did not do well; gold did very well.

Any views/analysis most welcome. And would you be worried about overall market directionality with his expected focus on China and tariffs?

Q: Good morning,


I am not crystal clear on the most tax efficient account to hold each of the above listed ETFs and before moving any of them to another type of account, I would very much appreciate your guidance on the most tax efficient type of account to hold each of the above listed ETFs.

The above listed ETFs are all held in our family Registered (RRSP/TFSA/RESP) and Non-Registered accounts.

Thank you and I'll await your sage advice.

Q: What are your thoughts on their earnings and forward earnings.

Thanks for the great service

Q: Me, would like 5iR's take/opinion on 2 measures - Piotroski Score where a higher scores classify a stock as a strong financial position, and also Altman Score that helps investors to gauge the probability of a company going bankrupt ........Keen to hear what you have to say about these two measures/scores......Thanks.....Tom

Q: Sangoma stock keeps moving higher. Time to jump back in based on the valuation alone?